Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Acrivon Therapeutics, Inc. | 146,953 | reported | 18 May 2026 | tx 22+653,097−28,136 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 May 2026 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 72,981 | 0.00 USD | |
| 14 May 2026 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 613 | 1.92 USD | |
| 01 Mar 2026 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 186,728 | 0.00 USD | deriv |
| 14 Feb 2026 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 723 | 1.63 USD | |
| 13 Jan 2026 | PURCHASE | Acrivon Therapeutics, Inc. | 10,000 | 1.72 USD | |
| 14 Nov 2025 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 613 | 2.24 USD | |
| 14 Aug 2025 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 613 | 1.39 USD | |
| 14 May 2025 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 613 | 1.14 USD | |
| 01 Mar 2025 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 140,540 | 0.00 USD | deriv |
| 14 Feb 2025 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 724 | 5.42 USD | |
| 01 Mar 2024 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 90,090 | 0.00 USD | deriv |
| 14 Nov 2024 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 613 | 7.92 USD | |
| 14 Aug 2024 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 613 | 7.02 USD | |
| 17 May 2024 | EXERCISE | Acrivon Therapeutics, Inc. | 10,000 | 1.04 USD | |
| 17 May 2024 | EXERCISE | Acrivon Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 14 May 2024 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 613 | 8.36 USD | |
| 14 Feb 2024 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 723 | 3.40 USD | |
| 14 Nov 2023 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 2,450 | 5.08 USD | |
| 05 Jun 2023 | EXERCISE | Acrivon Therapeutics, Inc. | 9,225 | 1.04 USD | |
| 05 Jun 2023 | EXERCISE | Acrivon Therapeutics, Inc. | 9,225 | 0.00 USD | deriv |
| 14 Nov 2022 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 33,383 | 0.00 USD | |
| 14 Nov 2022 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 100,150 | 0.00 USD | deriv |